Study on the mechanism of pirfenidone in the treatment of connective tissue disease with interstitial lung disease Study on the mechanism of pirfenidonein the treatment of connective tissue disease with interstitial ...
Study on the mechanism of pirfenidone in the treatment of connective tissue disease with interstitial lung disease Study on the mechanism of pirfenidonein the treatment of connective tissue disease with interstitial ...
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy o ...
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease - TRAIL1 A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy o ...
Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients With Rheumatoid Arthritis Interstitial Lung Disease (TRAIL1) Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidonein Patients With Rheumatoid Arthrit ...